CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Ciprofloxacin In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Ciprofloxacin In Dextrose 5% In Plastic Container launch?
Ciprofloxacin In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Bedford, Hikma Farmaceutica, Hospira, Inforlife, and Teva Pharms. and is included in seven NDAs.
The generic ingredient in CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER is ciprofloxacin. There are thirty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ciprofloxacin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ciprofloxacin In Dextrose 5% In Plastic Container
A generic version of CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as ciprofloxacin by BAXTER HLTHCARE CORP on April 29th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 301 |
| DailyMed Link: | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Cancer Research, United Kingdom | Phase 1/Phase 2 |
| Prostate Cancer Foundation | Phase 1/Phase 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 |
See all CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Pharmacology for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
| Drug Class | Fluoroquinolone Antibacterial Quinolone Antimicrobial |
| Mechanism of Action | Cytochrome P450 1A2 Inhibitors |
US Patents and Regulatory Information for CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 077888-001 | Mar 18, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Farmaceutica | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 078431-001 | Nov 18, 2009 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Baxter Hlthcare Corp | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 078024-002 | Mar 18, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 077138-001 | Mar 18, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
